다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Bolt Biotherapeutics Inc (BOLT)
Bolt Biotherapeutics Inc (BOLT) 뉴스

BOLT

Bolt Biotherapeutics (BOLT)

Bolt Biotherapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:BOLT

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/15	07:54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BOLT	Bolt Biotherapeutics Inc
2024/06/15	07:45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BOLT	Bolt Biotherapeutics Inc
2024/06/15	02:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BOLT	Bolt Biotherapeutics Inc
2024/05/21	02:22	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:BOLT	Bolt Biotherapeutics Inc
2024/05/16	06:43	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:BOLT	Bolt Biotherapeutics Inc
2024/05/15	05:14	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:BOLT	Bolt Biotherapeutics Inc
2024/05/15	05:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BOLT	Bolt Biotherapeutics Inc
2024/05/15	05:05	GlobeNewswire Inc.	Bolt Biotherapeutics Reports First Quarter 2024 Results, Announces Strategic Pipeline Prioritization and Changes to Leadership Team	NASDAQ:BOLT	Bolt Biotherapeutics Inc
2024/03/22	05:05	GlobeNewswire Inc.	Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update	NASDAQ:BOLT	Bolt Biotherapeutics Inc
2024/03/07	03:29	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BOLT	Bolt Biotherapeutics Inc
2024/03/07	03:27	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BOLT	Bolt Biotherapeutics Inc
2024/02/27	21:00	GlobeNewswire Inc.	Bolt Biotherapeutics to Present at the TD Cowen 44th Annual Healthcare Conference	NASDAQ:BOLT	Bolt Biotherapeutics Inc
2024/02/13	11:41	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:BOLT	Bolt Biotherapeutics Inc
2024/02/07	03:09	Edgar (US Regulatory)	Form 5 - Annual statement of changes in beneficial ownership of securities	NASDAQ:BOLT	Bolt Biotherapeutics Inc
2023/12/21	21:30	GlobeNewswire Inc.	Pacira Appoints Frank D. Lee as Chief Executive Officer	NASDAQ:BOLT	Bolt Biotherapeutics Inc
2023/12/14	03:40	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BOLT	Bolt Biotherapeutics Inc
2023/12/05	21:00	GlobeNewswire Inc.	Bolt Biotherapeutics Enrolls First Patient in Phase 2 Clinical Study Evaluating BDC-1001 in Patients with HER2-Positive Breast Cancer Previously Treated with Enhertu®	NASDAQ:BOLT	Bolt Biotherapeutics Inc
2023/11/10	06:10	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:BOLT	Bolt Biotherapeutics Inc
2023/11/10	06:08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BOLT	Bolt Biotherapeutics Inc
2023/11/10	06:05	GlobeNewswire Inc.	Bolt Biotherapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update	NASDAQ:BOLT	Bolt Biotherapeutics Inc
2023/11/07	21:00	GlobeNewswire Inc.	Bolt Biotherapeutics to Present at Stifel 2023 Healthcare Conference	NASDAQ:BOLT	Bolt Biotherapeutics Inc
2023/10/23	23:30	GlobeNewswire Inc.	Bolt Biotherapeutics Presents Updated Clinical Data from Phase 1 Dose-Escalation Trial of BDC-1001 as Monotherapy and in Combination with Nivolumab in HER2-Expressing Tumors at ESMO 2023 Congress	NASDAQ:BOLT	Bolt Biotherapeutics Inc
2023/10/18	20:00	GlobeNewswire Inc.	Bolt Biotherapeutics to Present Data at the Society for Immunotherapy of Cancer’s 2023 Annual Meeting	NASDAQ:BOLT	Bolt Biotherapeutics Inc
2023/10/17	20:00	GlobeNewswire Inc.	Bolt Biotherapeutics Announces First Patient Dosed in Phase 1/2 Study of BDC-3042 in Patients with Advanced Cancers	NASDAQ:BOLT	Bolt Biotherapeutics Inc
2023/10/16	20:00	GlobeNewswire Inc.	Bolt Biotherapeutics to Present New Clinical Data from Completed Phase 1/2 Dose-Escalation Trial of BDC-1001 in HER2-Expressing Solid Tumors at the ESMO Congress 2023	NASDAQ:BOLT	Bolt Biotherapeutics Inc
2023/09/28	20:00	GlobeNewswire Inc.	Bolt Biotherapeutics Receives Orphan Drug Designation for BDC-1001 for Treatment of Gastric Cancers	NASDAQ:BOLT	Bolt Biotherapeutics Inc
2023/09/12	21:05	GlobeNewswire Inc.	Bolt Biotherapeutics Announces Issuance of U.S. Patent Covering Dectin-2-Targeting Agonist Antibodies, Including BDC-3042	NASDAQ:BOLT	Bolt Biotherapeutics Inc
2023/09/06	05:15	GlobeNewswire Inc.	Bolt Biotherapeutics to Participate in September Investor Conferences	NASDAQ:BOLT	Bolt Biotherapeutics Inc
2023/08/08	05:10	GlobeNewswire Inc.	Bolt Biotherapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update	NASDAQ:BOLT	Bolt Biotherapeutics Inc
2023/08/08	05:08	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:BOLT	Bolt Biotherapeutics Inc

검색 관련기사 보기:NASDAQ:BOLT

1 2 3 4 5 6 7 8 9 10 다음 >>

American Express

Bank of America

US Dollar vs Sterling

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관